@ARTICLE{
author={Bozovic-Spasojevic Ivana M,Milovic-Kovacevic Marijana M,Lekic S,Cvetanovic A,Kolarov-Bjelobrk Ivana N,Lucic J,Andric Zoran G,Milenkovic D,...,Vukovic I,Petronijevic M,Calamac Marina D,Djurmez Ognjen,Djuric S,Perduv V,Radisavljevic M,Popovic Lazar S},
year={2025},
title={Real-world treatment patterns in patients with human epidermal growth factor receptor 2 (HER2) - positive early breast cancer in Serbia and Montenegro - HEReNA},
journal={BREAST},
volume={80},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={O'Shaughnessy J,...,Popovic Lazar S,...,Vojnovic Z,...,Milenkovic D,...,(broj koautora 23)},
year={2019},
title={Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results},
journal={CANCER RESEARCH},
volume={79},
number={4},
pages={-},
document_type={Meeting Abstract},
}